Biocidal mechanism of green synthesized thyme loaded silver nanoparticles (GTAgNPs) against immune evading tricky methicillin-resistant Staphylococcus aureus 090 (MRSA090) at a homeostatic environment

[Display omitted] The tricky defense mechanism of methicillin-resistant Staphylococcus aureus (MRSA) 090 easily evades innate immune system to establish its journey in the body. Till today, the exact mechanism and toxicity of green silver nanoparticles to bacteria is an elusive question. To address...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arabian journal of chemistry 2020-01, Vol.13 (1), p.1179-1197
Hauptverfasser: Manukumar, H.M., Yashwanth, B., Umesha, S., Venkateswara Rao, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] The tricky defense mechanism of methicillin-resistant Staphylococcus aureus (MRSA) 090 easily evades innate immune system to establish its journey in the body. Till today, the exact mechanism and toxicity of green silver nanoparticles to bacteria is an elusive question. To address this issue, synthesized a green thyme loaded silver nanoparticles (GTAgNPs), characterized and its toxicity to MRSA090 was evaluated. The synthesized GTAgNPs showed controlled the particle size of 75nm having anti-microbial property effective at 1mg/mL confirmed by membrane destabilization validated by surface alterations through bioelectrochemistry, SEM., and AFM. The GTAgNPs showed negligible toxicity to PBMC and anti-cancer property against A549 and MCF-7 cell lines. The blood compatibility of GTAgNPs, delaying coagulation, and down-regulating the virulence genes MRSA090 such as Coa and SpA. These studies conclude the GTAgNPs tested the first time against MRSA090 and strongly presume that designing of the anti-staphylococcal drug from an active molecule of thyme plant being a natural source can gain more attention for medicine against MRSA infections in future.
ISSN:1878-5352
1878-5379
DOI:10.1016/j.arabjc.2017.09.017